From three-dimensional GPCR structure to rational ligand discovery.

Area of Science:

• Biochemistry
• Pharmacology
• Computational Chemistry

Background:

• G protein-coupled receptors (GPCRs) are crucial drug targets.
• Structure-based drug design offers a powerful approach for GPCR ligand discovery.
• Advancements in GPCR structural biology enhance virtual screening capabilities.

Purpose of the Study:

• To introduce a generic workflow for structure-based virtual screening of GPCRs.
• To discuss methods for ligand design and hit optimization using GPCR structures.
• To highlight recent successes and challenges in GPCR-targeted drug discovery.

Main Methods:

• Utilizing experimental data to guide virtual screening.
• Predicting ligand binding modes to GPCRs.
• Performing virtual screening for novel ligands.
• Optimizing screening hits through structure-based design.

Main Results:

• Receptor models, even with inaccuracies, are effective for novel GPCR ligand identification.
• Recently solved GPCR crystal structures expand opportunities for structure-based design.
• Successful structure-based ligand discovery studies demonstrate the approach's utility.

Conclusions:

• Structure-based virtual screening is a viable strategy for GPCR drug discovery.
• GPCR crystal structures significantly enhance rational ligand design.
• Challenges remain in identifying pathway-specific ligands and optimizing fragment-like molecules.